[시장보고서]세계의 포유류 세포은행 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

세계의 포유류 세포은행 시장 : 업계 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Mammalian Cell Banking Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1701683

리서치사 : Persistence Market Research

발행일 : 2025년 04월

페이지 정보 : 영문 251 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,261,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,604,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,349,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 포유류 세포은행 시장 규모는 2025년에 5억 6,700만 달러에 달ㅎ마고, 2025-2032년의 예측 기간 동안 14.0%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 14억 1,880만 달러에 달할 것으로 예상됩니다.

포유류 세포은행 시장에는 생물 의약품 제조, 유전자 치료, 백신 제조에 필수적인 포유류 세포 유래 세포주의 개발, 보관, 유지관리가 포함됩니다. 세포은행은 바이오의약품 제조의 일관성, 품질, 안전성을 보장합니다. 전 세계적으로 단클론항체, 세포 및 유전자 치료, 맞춤 의료에 대한 수요가 증가함에 따라 포유류 세포 은행은 신뢰할 수 있고 확장성이 높은 생산 공정을 보장하는 데 중요한 요소로 자리 잡고 있습니다.

포유류 세포은행 시장은 몇 가지 강력한 요인에 의해 강력한 성장을 보이고 있습니다. 주요 촉진요인은 생물학적 제제 및 바이오시밀러에 대한 수요 증가이며, 이러한 제제는 생산에 안정적이고 잘 특성화된 포유류 세포주를 필요로 합니다. 개인 맞춤형 의료와 세포 및 유전자 치료에 대한 관심이 높아짐에 따라 안전하고 고품질의 세포은행 시스템의 필요성이 더욱 가속화되고 있으며, CRISPR 기반 엔지니어링 및 하이스루풋 스크리닝과 같은 세포주 개발 기술의 발전도 시장 확대에 기여하고 있습니다. 또한, 세포은행에서 우수의약품 제조기준(GMP) 사용에 대한 규제 당국의 지원은 제품 품질과 규정 준수를 강화하여 시장을 발전시키고 있습니다.

포유류 세포은행 시장은 성장 잠재력에도 불구하고 몇 가지 과제에 직면해 있습니다. 특히 중소기업의 경우, GMP 준수 시설 설립에 따른 높은 초기 투자 및 운영 비용이 큰 장벽이 될 수 있습니다. 또한, 새로운 세포주에 대한 복잡하고 시간이 오래 걸리는 규제 당국의 승인 절차는 제품 개발을 지연시킬 수 있습니다. 또한, 오염, 유전자 드리프트, 장기 보관 시 변동과 관련된 리스크가 있어 엄격한 품질 관리 및 모니터링 시스템이 필요하며, 이는 비용과 복잡성을 증가시키는 요인으로 작용합니다.

포유류 세포은행 시장은 확장 및 혁신의 기회를 제공합니다. 특히 종양학 및 희귀질환에서 생물학적 제제 및 첨단 치료법을 포함한 임상시험이 증가함에 따라 다양하고 신뢰할 수 있는 세포은행에 대한 수요가 증가하고 있습니다. 아시아태평양과 라틴아메리카의 신흥 시장은 바이오 의약품 생산 능력을 빠르게 확장하고 있으며, 새로운 비즈니스 전망을 제공합니다. 또한, 바이오 제약사와 CRO가 세포은행 서비스를 공동으로 아웃소싱하는 사례가 증가하면서 확장성과 효율성이 향상되고 있으며, AI를 활용한 품질 관리 및 디지털 바이오뱅킹 플랫폼과 같은 자동화 및 디지털 기술에 대한 투자도 표준화와 운영의 우수성을 높일 수 있는 기회를 제공합니다. 표준화와 운영의 우수성을 높일 수 있는 문을 열어줍니다.

세계의 포유류 세포은행 시장에 대해 조사했으며, 세포별/기술별/용도별/최종사용자별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 정리하여 전해드립니다.

영문목차

Persistence Market Research has recently released a comprehensive report on the global Mammalian Cell Banking Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Mammalian Cell Banking Market Size (2025E): USD 567.0 Mn
Projected Market Value (2032F): USD 1,418.8 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 14.0%

Mammalian Cell Banking Market - Report Scope:

The mammalian cell banking market includes the development, storage, and maintenance of cell lines derived from mammalian cells, which are essential for biologics manufacturing, gene therapy, and vaccine production. Cell banks ensure consistency, quality, and safety in the production of biopharmaceuticals. As demand for monoclonal antibodies, cell and gene therapies, and personalized medicine increases globally, mammalian cell banking has become a critical component in ensuring reliable and scalable production processes.

Market Growth Drivers:

The mammalian cell banking market is experiencing strong growth driven by several influential factors. A major driver is the rising demand for biologics and biosimilars, which require stable and well-characterized mammalian cell lines for production. The increasing focus on personalized medicine and cell & gene therapies has further accelerated the need for secure and high-quality cell banking systems. Technological advancements in cell line development, such as CRISPR-based engineering and high-throughput screening, are also contributing to market expansion. In addition, regulatory support for the use of Good Manufacturing Practices (GMP) in cell banking enhances product quality and compliance, propelling the market forward.

Market Restraints:

Despite its growth potential, the mammalian cell banking market faces some challenges. High initial investment and operational costs associated with establishing GMP-compliant facilities can be a significant barrier, especially for small and mid-sized enterprises. Moreover, the complex and time-consuming regulatory approval processes for new cell lines can delay product development. There are also risks associated with contamination, genetic drift, or variability in long-term storage, which necessitate stringent quality control and monitoring systems, adding to the cost and complexity.

Market Opportunities:

The mammalian cell banking market presents numerous opportunities for expansion and innovation. The increasing number of clinical trials involving biologics and advanced therapies, particularly in oncology and rare diseases, is creating demand for diverse and reliable cell banks. Emerging markets in Asia-Pacific and Latin America are rapidly expanding their biopharmaceutical manufacturing capabilities, offering new business prospects. In addition, collaborations between biopharma companies and CROs to outsource cell banking services are on the rise, enabling scalability and efficiency. Investment in automation and digital technologies, such as AI-driven quality control and digital biobanking platforms, also opens doors for greater standardization and operational excellence.

Key Questions Answered in the Report:

What are the primary factors driving the global mammalian cell banking market's growth?
Which cell types and applications are dominating the mammalian cell banking landscape?
How are biopharmaceutical trends shaping future cell banking strategies?
Who are the key players in the mammalian cell banking market, and what strategies are they adopting?
What are the growth opportunities in emerging regions?

Competitive Intelligence and Business Strategy:

Leading companies in the mammalian cell banking market, such as Eurofins DiscoverX Corporation, Merck KGaA, Sartorius Stedim BioOutsource Limited, Charles River Laboratories, and Lonza Group Ltd, are focusing on expanding their GMP-compliant manufacturing facilities and enhancing service portfolios to meet global biopharma demand. Strategic partnerships with biotech firms and academic institutes, along with R&D investments in innovative cell line technologies, are key to maintaining a competitive edge. Companies are also emphasizing quality assurance, contamination prevention, and regulatory alignment to boost client confidence and streamline product development pipelines.

Companies Covered in This Report:

Eurofins DiscoverX Corporation
Merck KGaA
Sartorius Stedim BioOutsource Limited
Charles River Laboratories
Altogen Labs
Abzena Ltd
Northway Biotechpharma
Lonza Group Ltd
VIRUSURE
Selexis SA
Takara Bio Inc

Key Segments Covered in Manufacturing of Industry Research:

Cell Type:

CHO
BHK
NS0
YB2/0 & P2/0
HEK293 & Derivatives
HELA

Technology:

Application:

MCB (Master Cell Bank)
WCB (Working Cell Bank)
EoP (End of Production)
R&D CB (Research & Development Cell Bank)

End User:

Academic & Research Institutes
Biopharmaceutical Companies
CROs (Contract Research Organizations)

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply-Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Development/Innovation Trends

4. Key Success Factors

4.1. Pipeline Assessment
4.2. Value chain Analysis
4.3. Key Promotional Strategies, By Key Manufacturers
4.4. Regulatory Landscape
4.5. PESTLE Analysis
4.6. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Expenditure
- 5.1.3. Global Cell Banking Outsourcing Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Key Player's Historic Growth
- 5.2.2. Market Consolidation Activities
- 5.2.3. Increasing Geriatric Population
- 5.2.4. Rising Cases of Cancer
- 5.2.5. Growing Preference of Mammalian Cell Banking
- 5.2.6. Increased R&D investments by Government
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Cell
- 6.1.2. By Technology
- 6.1.3. By Application
- 6.1.4. By End User
- 6.1.5. By Region
6.2. 2022 Market Scenario

7. Global Mammalian Cell Banking Market Outlook, 2019-2032

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Cell

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Cell, 2019-2024
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cell, 2025-2032
8.4. Market Attractiveness Analysis By Cell

9. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Technology

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) By Technology, 2019-2024
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2025-2032
9.4. Market Attractiveness Analysis By Technology

10. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Application

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2024
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2025-2032
10.4. Market Attractiveness Analysis By Application

11. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By End User

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) By End User, 2019-2024
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
- 11.3.1. Academic & Research Institute
- 11.3.2. Biopharmaceutical Companies
- 11.3.3. CROs
11.4. Market Attractiveness Analysis By End User

12. Global Mammalian Cell Banking Market Outlook, 2019-2032 , By Region

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
12.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
- 12.3.1. North America
- 12.3.2. Latin America
- 12.3.3. Europe
- 12.3.4. East Asia
- 12.3.5. South Asia
- 12.3.6. Oceania
- 12.3.7. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region

13. North America Mammalian Cell Banking Market Outlook, 2019-2032

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 13.3.1. By Country
  - 13.3.1.1. U.S.
  - 13.3.1.2. Canada
13.4. Market Attractiveness Analysis
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. U.S. Mammalian Cell Banking Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 13.8.2. Canada Mammalian Cell Banking Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy

14. Latin America Mammalian Cell Banking Market Outlook, 2019-2032

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 14.3.1. By Country
  - 14.3.1.1. Mexico
  - 14.3.1.2. Brazil
  - 14.3.1.3. Argentina
  - 14.3.1.4. Rest of Latin America
14.4. Market Attractiveness Analysis
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Mexico Mammalian Cell Banking Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.2. Brazil Mammalian Cell Banking Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 14.8.3. Argentina Mammalian Cell Banking Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy

15. Europe Mammalian Cell Banking Market Outlook, 2019-2032

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 15.3.1. By Country
  - 15.3.1.1. Italy
  - 15.3.1.2. Germany
  - 15.3.1.3. U.K
  - 15.3.1.4. France
  - 15.3.1.5. Spain
  - 15.3.1.6. BENELUX
  - 15.3.1.7. Nordic Countries
  - 15.3.1.8. Russia
  - 15.3.1.9. Rest of Europe
15.4. Market Attractiveness Analysis
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. Italy Mammalian Cell Banking Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.2. Germany Mammalian Cell Banking Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.3. U.K. Mammalian Cell Banking Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.4. France Mammalian Cell Banking Market Analysis
  - 15.8.4.1. Introduction
  - 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.5. Spain Mammalian Cell Banking Market Analysis
  - 15.8.5.1. Introduction
  - 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.6. BENELUX Mammalian Cell Banking Market Analysis
  - 15.8.6.1. Introduction
  - 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.7. Nordic Countries Mammalian Cell Banking Market Analysis
  - 15.8.7.1. Introduction
  - 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
- 15.8.8. Russia Mammalian Cell Banking Market Analysis
  - 15.8.8.1. Introduction
  - 15.8.8.2. Market Analysis and Forecast by Market Taxonomy

16. South Asia Mammalian Cell Banking Market Outlook, 2019-2032

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Cell
16.4. Market Attractiveness Analysis
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Mammalian Cell Banking Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.2. Indonesia Mammalian Cell Banking Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.3. Malaysia Mammalian Cell Banking Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
- 16.8.4. Thailand Mammalian Cell Banking Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy

17. East Asia Mammalian Cell Banking Market Outlook, 2019-2032

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
17.4. Market Attractiveness Analysis
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. China Mammalian Cell Banking Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.2. Japan Mammalian Cell Banking Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
- 17.8.3. South Korea Mammalian Cell Banking Market Analysis
  - 17.8.3.1. Introduction
  - 17.8.3.2. Market Analysis and Forecast by Market Taxonomy

18. Oceania Mammalian Cell Banking Market 2019-2024 and Forecast 2025-2032

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 18.3.1. By Country
  - 18.3.1.1. Australia
  - 18.3.1.2. New Zealand
18.4. Market Attractiveness Analysis
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. Australia Mammalian Cell Banking Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 18.8.2. New Zealand Mammalian Cell Banking Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy

19. Middle East and Africa (MEA) Mammalian Cell Banking Market Outlook, 2019-2032

19.1. Introduction
19.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2024
19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2025-2032
- 19.3.1. By Country
  - 19.3.1.1. GCC Countries
  - 19.3.1.2. Turkey
  - 19.3.1.3. South Africa
  - 19.3.1.4. North Africa
  - 19.3.1.5. Rest of Middle East and Africa
19.4. Market Attractiveness Analysis
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
- 19.8.1. GCC Countries Mammalian Cell Banking Market Analysis
  - 19.8.1.1. Introduction
  - 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
- 19.8.2. Turkey Mammalian Cell Banking Market Analysis
- 19.8.3. South Africa Mammalian Cell Banking Market Analysis
- 19.8.4. North Africa Mammalian Cell Banking Market Analysis

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies
20.2. Market Share Analysis of Top Players (%)
20.3. Market Presence Analysis
- 20.3.1. By Regional Footprint of Players
- 20.3.2. Cell Footprint of Players
- 20.3.3. Channel Footprint of Players

21. Competition Analysis

21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
- 21.3.1. Eurofins DiscoverX Corporation
  - 21.3.1.1. Overview
  - 21.3.1.2. Product & Services Portfolio
  - 21.3.1.3. Key Financials
  - 21.3.1.4. SWOT Analysis
  - 21.3.1.5. Key Developments
  - 21.3.1.6. Sales Footprint
  - 21.3.1.7. Strategy Overview
    - 21.3.1.7.1. Marketing Strategy
    - 21.3.1.7.2. Product Strategy
    - 21.3.1.7.3. Channel Strategy
- 21.3.2. Merck KGaA
- 21.3.3. Sartorius Stedim BioOutsource Limited.
- 21.3.4. Charles River Laboratories
- 21.3.5. Altogen Labs
- 21.3.6. Abzena Ltd
- 21.3.7. Northway Biotechpharma
- 21.3.8. Lonza Group Ltd
- 21.3.9. VIRUSURE
- 21.3.10. Selexis SA
- 21.3.11. Sigma-Aldrich
- 21.3.12. Takara Bio Inc

한글목차

목차

제1장 주요 요약

제2장 시장 개요

제3장 주요 시장 동향

제4장 중요 성공 요인

제5장 시장 배경

제6장 COVID-19 위기 - 영향 평가

제7장 세계의 포유류 세포은행 시장 전망, 2019년-2032년

제8장 세계의 포유류 세포은행 시장 전망, 2019년-2032년, 세포별

제9장 세계의 포유류 세포은행 시장 전망,2019-2032년, 기술별

제10장 세계의 포유류 세포은행 시장 전망, 2019년-203, 용도별

제11장 세계의 포유류 세포은행 시장 전망, 2019년-2032년, 최종사용자별

제12장 세계의 포유류 세포은행 시장 전망, 2019년-2032년, 지역별

제13장 북미의 포유류 세포은행 시장 전망, 2019년-2032년

제14장 라틴아메리카의 포유류 세포은행 시장 전망, 2019년-2032년

제15장 유럽의 포유류 세포은행 시장 전망, 2019년-2032년

제16장 남아시아의 포유류 세포은행 시장 전망, 2019년-2032년

제17장 동아시아의 포유류 세포은행 시장 전망, 2019년-2032년

제18장 오세아니아 포유류 세포은행 시장

제19장 중동 및 아프리카의 포유류 세포은행 시장 전망, 2019년-2032년

제20장 시장 구조 분석

제21장 경쟁 분석

제22장 전제와 사용된 두자어

제23장 조사 방법